Please login to the form below

Not currently logged in
Email:
Password:

Heart drug

This page shows the latest Heart drug news and features for those working in and with pharma, biotech and healthcare.

Amgen gets prevention claim for cholesterol drug Repatha

Amgen gets prevention claim for cholesterol drug Repatha

Amgen gets prevention claim for cholesterol drug Repatha. FDA approves new labelling on heart attack and stroke risk reduction. ... The US FDA has approved new labelling saying that Amgen’s cholesterol drug Repatha can reduce the risk of heart attacks

Latest news

  • Vas Narasimhan takes top Novartis job on Jimenez departure Vas Narasimhan takes top Novartis job on Jimenez departure

    Harvard -trained physician Narasimhan has been with Novartis since 2005 and has held a number of roles at the company across commercial, drug development and strategy but is "deeply anchored in ... showed an uptick in performance but remains under

  • Alcon's return to growth gives Novartis 'options', says CEO Alcon's return to growth gives Novartis 'options', says CEO

    Immunotherapy Cosentyx (secukinumab) for psoriasis, ankylosing spondylitis and psoriatic arthritis rocketed 90% to reach $490m in the quarter, while slow-burner Entresto (sacubitril and valsartan) for heart failure contributed $110m and ... A string of

  • New drugs can't keep Novartis sales on the up New drugs can't keep Novartis sales on the up

    The continued glacial growth of Novartis' heart failure hope Entresto weighed on its first-quarter results as sales declined on generic competition. ... year. A decision to drop development of acute heart failure drug serelaxin (RLX030) also pegged back

  • AZ data suggest SGLT2 inhibitors can reduce heart failure risk AZ data suggest SGLT2 inhibitors can reduce heart failure risk

    Real-world evidence has shown that treatment with the newer SGLT2 inhibitor class of diabetes drug can dramatically cut heart failure and death rates, says AstraZeneca. ... The similar outcome regardless of the individual drug and region also points to a

  • New outcomes data could unlock Repatha's potential, says Amgen New outcomes data could unlock Repatha's potential, says Amgen

    The results of a new trial promise to accelerate use of Amgen's cholesterol drug Repatha, which has seen slow take-up to date. ... In the four-year FOURIER trial - which involved 27, 500 patients - the drug significantly reduced the risk of heart attack,

More from news
Approximately 1 fully matching, plus 177 partially matching documents found.

Latest Intelligence

  • Transforming Access to Medicines Through Patient-Centric Solutions Transforming Access to Medicines Through Patient-Centric Solutions

    to medicines and the importance of putting patients at the heart of drug development and access. ... Patients at the heart of drug development and access. If you believe the news every day, patients are becoming more and more involved in drug development

  • Transforming Access to Medicines Through Patient-Centric Solutions Transforming Access to Medicines Through Patient-Centric Solutions

    to medicines and the importance of putting patients at the heart of drug development and access. ... Patients at the heart of drug development and access. If you believe the news every day, patients are becoming more and more involved in drug development

  • Heart failure therapy embarks on a new era Heart failure therapy embarks on a new era

    Ivabradine is thought to be the first drug to work by decreasing the heart rate as a consequence of its action on the If channel that controls the intrinsic pacemaker in ... In the 6, 500-patient SHIFT trial, for example, the drug showed a significant

  • Transforming times at AstraZeneca Transforming times at AstraZeneca

    She gives the example of a drug to prevent a second heart attack that has a positive NICE recommendation, can save people's lives and reduce further hospital costs. “ ... After a heart attack people tend to leave the hospital thinking the event is over.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics